☰

Sandeep Rana, Ph.D. - Publications

Affiliations: 
2009 Department of Chemistry Kansas State University, Manhattan, KS, United States 
Area:
Organic Chemistry, Biochemistry, Pharmaceutical Chemistry
Tree Info Similar researchers PubMed Report error

40 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Rana S, Dranchak P, Dahlin JL, Lamy L, Li W, Oliphant E, Shrimp JH, Rajacharya GH, Tharakan R, Holland DO, Whitten AS, Wilson KM, Singh PK, Durum SK, Tao D, et al. Methotrexate-based PROTACs as DHFR-specific chemical probes. Cell Chemical Biology. PMID 37875111 DOI: 10.1016/j.chembiol.2023.09.014  0.314
2022 Rana S, Kour S, Kizhake S, King HM, Mallareddy JR, Case AJ, Huxford T, Natarajan A. Dimers of isatin derived α-methylene-γ-butyrolactone as potent anti-cancer agents. Bioorganic & Medicinal Chemistry Letters. 65: 128713. PMID 35367592 DOI: 10.1016/j.bmcl.2022.128713  0.321
2021 Rana S, Mallareddy JR, Singh S, Boghean L, Natarajan A. Inhibitors, PROTACs and Molecular Glues as Diverse Therapeutic Modalities to Target Cyclin-Dependent Kinase. Cancers. 13. PMID 34771669 DOI: 10.3390/cancers13215506  0.637
2021 Sagar S, Singh S, Mallareddy JR, Sonawane YA, Napoleon JV, Rana S, Contreras JI, Rajesh C, Ezell EL, Kizhake S, Garrison JC, Radhakrishnan P, Natarajan A. Structure activity relationship (SAR) study identifies a quinoxaline urea analog that modulates IKKβ phosphorylation for pancreatic cancer therapy. European Journal of Medicinal Chemistry. 222: 113579. PMID 34098465 DOI: 10.1016/j.ejmech.2021.113579  0.304
2021 King HM, Rana S, Kubica SP, Mallareddy JR, Kizhake S, Ezell EL, Zahid M, Naldrett MJ, Alvarez S, Law HCH, Woods NT, Natarajan A. Aminopyrazole based CDK9 PROTAC sensitizes pancreatic cancer cells to venetoclax. Bioorganic & Medicinal Chemistry Letters. 128061. PMID 33895280 DOI: 10.1016/j.bmcl.2021.128061  0.305
2021 Al-Mugotir M, Lovelace JJ, George J, Bessho M, Pal D, Struble L, Kolar C, Rana S, Natarajan A, Bessho T, Borgstahl GEO. Selective killing of homologous recombination-deficient cancer cell lines by inhibitors of the RPA:RAD52 protein-protein interaction. Plos One. 16: e0248941. PMID 33784323 DOI: 10.1371/journal.pone.0248941  0.301
2020 Robb CM, Kour S, Contreras JI, Agarwal E, Barger CJ, Rana S, Sonawane Y, Neilsen BK, Taylor M, Kizhake S, Thakare RN, Chowdhury S, Wang J, Black JD, Hollingsworth MA, et al. Correction: Characterization of CDK(5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapy. Oncotarget. 11: 2462-2463. PMID 32637035 DOI: 10.18632/Oncotarget.27403  0.636
2020 Rana S, Kour S, Sonawane YA, Robb CM, Contreras JI, Kizhake S, Zahid M, Karpf AR, Natarajan A. Symbiotic Prodrugs (SymProDs) Dual Targeting of NFkappaB and CDK. Chemical Biology & Drug Design. PMID 32237047 DOI: 10.1111/Cbdd.13684  0.681
2020 Shamsi F, Hasan P, Queen A, Hussain A, Khan P, Zeya B, King HM, Rana S, Garrison J, Alajmi MF, Rizvi MMA, Zahid M, Imtaiyaz Hassan M, Abid M. Synthesis and SAR studies of novel 1,2,4-oxadiazole-sulfonamide based compounds as potential anticancer agents for colorectal cancer therapy. Bioorganic Chemistry. 98: 103754. PMID 32200329 DOI: 10.1016/J.Bioorg.2020.103754  0.376
2020 Tom EC, Mushtaq I, Mohapatra BC, Luan H, Bhat AM, Zutshi N, Chakraborty S, Islam N, Arya P, Bielecki TA, Iseka FM, Bhattacharyya S, Cypher LR, Goetz BT, Negi SK, ... ... Rana S, et al. EHD1 and RUSC2 control basal EGFR cell surface expression and recycling. Molecular and Cellular Biology. PMID 31932478 DOI: 10.1128/Mcb.00434-19  0.633
2019 Zheng XF, Acharya SS, Choe KN, Nikhil K, Adelmant G, Satapathy SR, Sharma S, Viccaro K, Rana S, Natarajan A, Sicinski P, Marto JA, Shah K, Chowdhury D. A mitotic CDK5-PP4 phospho-signaling cascade primes 53BP1 for DNA repair in G1. Nature Communications. 10: 4252. PMID 31534152 DOI: 10.1038/S41467-019-12084-X  0.616
2019 Kour S, Rana S, Contreras JI, King HM, Robb CM, Sonawane YA, Bendjennat M, Crawford AJ, Barger CJ, Kizhake S, Luo X, Hollingsworth MA, Natarajan A. CDK5 Inhibitor Downregulates Mcl-1 and Sensitizes Pancreatic Cancer Cell Lines to Navitoclax. Molecular Pharmacology. 96: 419-429. PMID 31467029 DOI: 10.1124/Mol.119.116855  0.698
2019 Rana S, Bendjennat M, Kour S, King HM, Kizhake S, Zahid M, Natarajan A. Selective degradation of CDK6 by a palbociclib based PROTAC. Bioorganic & Medicinal Chemistry Letters. PMID 30935795 DOI: 10.1016/J.Bmcl.2019.03.035  0.647
2018 Rana S, Sonawane YA, Taylor MA, Kizhake S, Zahid M, Natarajan A. Synthesis of aminopyrazole analogs and their evaluation as CDK inhibitors for cancer therapy. Bioorganic & Medicinal Chemistry Letters. PMID 30343954 DOI: 10.1016/J.Bmcl.2018.10.020  0.67
2018 Contreras JI, Robb CM, King HM, Baxter J, Crawford AJ, Kour S, Kizhake S, Sonawane YA, Rana S, Hollingsworth MA, Luo X, Natarajan A. Chemical Genetic Screens Identify Kinase Inhibitor Combinations that Target Anti-Apoptotic Proteins for Cancer Therapy. Acs Chemical Biology. PMID 29608269 DOI: 10.1021/Acschembio.8B00077  0.678
2018 Robb CM, Kour S, Contreras JI, Agarwal E, Barger CJ, Rana S, Sonawane Y, Neilsen BK, Taylor M, Kizhake S, Thakare RN, Chowdhury S, Wang J, Black JD, Hollingsworth MA, et al. Characterization of CDK(5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapy. Oncotarget. 9: 5216-5232. PMID 29435174 DOI: 10.18632/Oncotarget.23749  0.695
2018 Kumar B, Ahmad R, Rana S, Natarajan A, Dhawan P, Singh AB. Abstract 1350: Inhibiting VPS34 suppresses Wnt/beta-catenin signaling and promotes chemotherapeutic efficacy in colon cancer cells Cancer Research. 78: 1350-1350. DOI: 10.1158/1538-7445.Am2018-1350  0.682
2017 Abid M, A Sonawane Y, I Contreras J, Rana S, Natarajan A. Recent Advances in Cancer Drug Development: Targeting Induced Myeloid Cell Leukemia-1 (Mcl-1) Differentiation protein. Current Medicinal Chemistry. PMID 28901269 DOI: 10.2174/0929867324666170912092659  0.673
2017 Robb CM, Contreras JI, Kour S, Taylor MA, Abid M, Sonawane YA, Zahid M, Murry DJ, Natarajan A, Rana S. Chemically induced degradation of CDK9 by a proteolysis targeting chimera (PROTAC). Chemical Communications (Cambridge, England). PMID 28636052 DOI: 10.1039/C7Cc03879H  0.666
2017 Yefidoff-Freedman R, Fan J, Yan L, Zhang Q, Dos Santos GRRM, Rana S, Contreras JI, Sahoo R, Wan D, Yang J, Dias-Teixeira KL, Morisseau C, Du R, Halperin JA, Hammock BD, et al. Development of 1-((1,4-trans)-4-aryloxycyclohexyl)-3-arylurea Activators of the Heme Regulated Inhibitor as Selective Activators of Eucaryotic Translation Initiation Factor 2 Alpha (eIF2α) Phosphorylation Arm of the Integrated Endoplasmic Reticulum Stress Response. Journal of Medicinal Chemistry. PMID 28590739 DOI: 10.1021/Acs.Jmedchem.7B00059  0.648
2016 Sonawane YA, Taylor MA, Napoleon JV, Rana S, Contreras JI, Natarajan A. Cyclin dependent kinase 9 inhibitors for cancer therapy. Journal of Medicinal Chemistry. PMID 27171036 DOI: 10.1021/Acs.Jmedchem.6B00150  0.687
2016 Rana S, Blowers EC, Tebbe C, Contreras JI, Radhakrishnan P, Kizhake S, Zhou T, Rajule RN, Arnst J, Munkarah AR, Rattan R, Natarajan A. Isatin derived spirocyclic analogs with α-methylene-γ-butyrolactone as anticancer agents: A structure activity rela-tionship study. Journal of Medicinal Chemistry. PMID 27077228 DOI: 10.1021/Acs.Jmedchem.6B00400  0.658
2015 Maroni D, Rana S, Mukhopadhyay C, Natarajan A, Naramura M. A quinoxaline urea analog uncouples inflammatory and pro-survival functions of IKKβ. Immunology Letters. PMID 26518140 DOI: 10.1016/J.Imlet.2015.10.011  0.651
2015 Mundra V, Peng Y, Rana S, Natarajan A, Mahato RI. Micellar formulation of indocyanine green for phototherapy of melanoma. Journal of Controlled Release : Official Journal of the Controlled Release Society. 220: 130-140. PMID 26482083 DOI: 10.1016/J.Jconrel.2015.10.029  0.61
2015 Gautam N, Thakare R, Rana S, Natarajan A, Alnouti Y. Irreversible binding of an anticancer compound (BI-94) to plasma proteins. Xenobiotica; the Fate of Foreign Compounds in Biological Systems. 1-16. PMID 25869245 DOI: 10.3109/00498254.2015.1025250  0.61
2015 Rana S, Blowers EC, Natarajan A. Small molecule adenosine 5'-monophosphate activated protein kinase (AMPK) modulators and human diseases. Journal of Medicinal Chemistry. 58: 2-29. PMID 25122135 DOI: 10.1021/Jm401994C  0.636
2015 Rana S, Blowers E, Natarajan A. Abstract 3645: A non-ATP competitive IKKβ inhibitor for cancer therapy Cancer Research. 75: 3645-3645. DOI: 10.1158/1538-7445.Am2015-3645  0.681
2013 Chen T, Takrouri K, Hee-Hwang S, Rana S, Yefidoff-Freedman R, Halperin J, Natarajan A, Morisseau C, Hammock B, Chorev M, Aktas BH. Explorations of substituted urea functionality for the discovery of new activators of the heme-regulated inhibitor kinase. Journal of Medicinal Chemistry. 56: 9457-70. PMID 24261904 DOI: 10.1021/Jm400793V  0.644
2013 Dou D, Park JG, Rana S, Madden BJ, Jiang H, Pang YP. Novel selective and irreversible mosquito acetylcholinesterase inhibitors for controlling malaria and other mosquito-borne diseases. Scientific Reports. 3: 1068. PMID 23323211 DOI: 10.1038/Srep01068  0.311
2013 Rana S, Natarajan A. Face selective reduction of the exocyclic double bond in isatin derived spirocyclic lactones. Organic & Biomolecular Chemistry. 11: 244-7. PMID 23160888 DOI: 10.1039/C2Ob27008K  0.591
2010 Hong HS, Maezawa I, Budamagunta M, Rana S, Shi A, Vassar R, Liu R, Lam KS, Cheng RH, Hua DH, Voss JC, Jin LW. Candidate anti-A beta fluorene compounds selected from analogs of amyloid imaging agents. Neurobiology of Aging. 31: 1690-9. PMID 19022536 DOI: 10.1016/J.Neurobiolaging.2008.09.019  0.673
2009 Pang YP, Ekström F, Polsinelli GA, Gao Y, Rana S, Hua DH, Andersson B, Andersson PO, Peng L, Singh SK, Mishra RK, Zhu KY, Fallon AM, Ragsdale DW, Brimijoin S. Selective and irreversible inhibitors of mosquito acetylcholinesterases for controlling malaria and other mosquito-borne diseases. Plos One. 4: e6851. PMID 19714254 DOI: 10.1371/Journal.Pone.0006851  0.606
2009 Trushina E, Rana S, McMurray CT, Hua DH. Tricyclic pyrone compounds prevent aggregation and reverse cellular phenotypes caused by expression of mutant huntingtin protein in striatal neurons. Bmc Neuroscience. 10: 73. PMID 19586540 DOI: 10.1186/1471-2202-10-73  0.609
2009 Hong HS, Rana S, Barrigan L, Shi A, Zhang Y, Zhou F, Jin LW, Hua DH. Inhibition of Alzheimer's amyloid toxicity with a tricyclic pyrone molecule in vitro and in vivo. Journal of Neurochemistry. 108: 1097-1108. PMID 19141069 DOI: 10.1111/J.1471-4159.2008.05866.X  0.682
2009 Rana S, Hong HS, Barrigan L, Jin LW, Hua DH. Syntheses of tricyclic pyrones and pyridinones and protection of Abeta-peptide induced MC65 neuronal cell death. Bioorganic & Medicinal Chemistry Letters. 19: 670-4. PMID 19121940 DOI: 10.1016/J.Bmcl.2008.12.060  0.631
2008 Ganta C, Shi A, Battina SK, Pyle M, Rana S, Hua DH, Tamura M, Troyer D. Combination of nanogel polyethylene glycol-polyethylenimine and 6(hydroxymethyl)-1,4-anthracenedione as an anticancer nanomedicine. Journal of Nanoscience and Nanotechnology. 8: 2334-40. PMID 18572646 DOI: 10.1166/Jnn.2008.294  0.733
2008 Shi A, Nguyen TA, Battina SK, Rana S, Takemoto DJ, Chiang PK, Hua DH. Synthesis and anti-breast cancer activities of substituted quinolines. Bioorganic & Medicinal Chemistry Letters. 18: 3364-8. PMID 18457950 DOI: 10.1016/J.Bmcl.2008.04.024  0.726
2008 Hua DH, Rana S, Hong H, Roberts L, Shi A, Jin L. P2-331: Counteraction of protein misfolding in Alzheimer's disease Alzheimer's & Dementia. 4: T469-T469. DOI: 10.1016/J.Jalz.2008.05.1408  0.651
2007 Hong HS, Maezawa I, Yao N, Xu B, Diaz-Avalos R, Rana S, Hua DH, Cheng RH, Lam KS, Jin LW. Combining the rapid MTT formazan exocytosis assay and the MC65 protection assay led to the discovery of carbazole analogs as small molecule inhibitors of Aβ oligomer-induced cytotoxicity Brain Research. 1130: 223-234. PMID 17157826 DOI: 10.1016/J.Brainres.2006.10.093  0.634
2006 Maezawa I, Hong HS, Wu HC, Battina SK, Rana S, Iwamoto T, Radke GA, Pettersson E, Martin GM, Hua DH, Jin LW. A novel tricyclic pyrone compound ameliorates cell death associated with intracellular amyloid-beta oligomeric complexes. Journal of Neurochemistry. 98: 57-67. PMID 16805796 DOI: 10.1111/J.1471-4159.2006.03862.X  0.746
Show low-probability matches.